Neovacs S.A. (EPA:ALNEV)

Neovacs Revenue

Neovacs had revenue of 157.72K EUR in the half year ending June 30, 2025, with 54.07% growth. This brings the company's revenue in the last twelve months to 199.27K, down -75.80% year-over-year. In the year 2024, Neovacs had annual revenue of 433.94K, down -18.65%.

• Revenue (ttm): 199.27K
• Revenue Growth: -75.80%
• P/S Ratio: 0.00
• Revenue / Employee: 12.45K
• Employees: 16
• Market Cap: 906.00

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	433.94K	-99.48K	-18.65%
Dec 31, 2023	533.41K	532.30K	47,868.71%
Dec 31, 2022	1.11K	-21.43K	-95.07%
Dec 31, 2021	22.54K	-7.24K	-24.32%
Dec 31, 2020	29.78K	-65.37K	-68.70%